Drugs Online |
 |
 | ||
|
MISOPT Cosopt |
|
| ||
Drugs Online » Prescription Drugs 11 » MISOPT Cosopt Cosopt lowers high pressure in the eye a problem typically caused by the condition known as open-angle glaucoma. Cosopt works by reducing production of the liquid that fills the eyeball. Dorzolamide ophthalmic reduces the amount of fluid in the eye which decreases pressure inside the eye. Timolol ophthalmic is a beta-blocker that also reduces pressure inside the eye.The combination of dorzolamide and timolol ophthalmic is used to treat certain types of glaucoma and other causes of high pressure inside the eye. Buy MISOPT Cosopt and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About MISOPT Cosopt: Product Type: Prescription Drugs 11 MISOPT ( Cosopt Dorzox-T Generic Dorzolamide/Timolol ) MISOPT (Cosopt Dorzox-T Generic Dorzolamide/Timolol) Cosopt Dorzox-T Generic Dorzolamide/Timolol 20mg/5mg Cosopt Dorzox-T Generic Dorzolamide/Timolol MISOPT
View more Prescription Drugs 11 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
